Journey Medical Corporation (DERM)
Automate Your Wheel Strategy on DERM
With Tiblio's Option Bot, you can configure your own wheel strategy including DERM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DERM
- Rev/Share 2.4874
- Book/Share 0.9527
- PB 8.156
- Debt/Equity 1.1683
- CurrentRatio 1.3422
- ROIC -0.1491
- MktCap 181008117.0
- FreeCF/Share -0.9703
- PFCF -8.2501
- PE -21.1596
- Debt/Assets 0.2962
- DivYield 0
- ROE -0.5203
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | DERM | Rodman & Renshaw | -- | Buy | -- | $9 | Aug. 22, 2024 |
News
Top 3 Health Care Stocks That May Crash In Q2
Published: April 07, 2025 by: Benzinga
Sentiment: Negative
As of April 7, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Read More
Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
Published: April 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Journey Medical (DERM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read More
Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript
Published: March 26, 2025 by: Seeking Alpha
Sentiment: Neutral
Journey Medical Corporation (NASDAQ:DERM ) Q4 2024 Results Conference Call March 26, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Chief Financial Officer Louis Donati - Director of Market Access Srini Sidgiddi - Vice President, Research and Development Ramsey Alloush - General Counsel and Corporate Secretary Conference Call Participants Thomas Flaten - Lake Street Capital Markets Scott Henry - AGP Brandon Folkes - Rodman & Renshaw Jason Wittes - Roth Capital Kalpit Patel - B. Riley Securities Operator Ladies and gentlemen, thank you for standing …
Read More
Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Journey Medical Corporation (DERM) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.12 per share a year ago.
Read More
About Journey Medical Corporation (DERM)
- IPO Date 2021-11-12
- Website https://journeymedicalcorp.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Claude Maraoui
- Employees 41